APO Research
Talk to an analyst

APO RESEARCH · REPORT

Androgen and Anabolic Steroid

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Androgen and Anabolic Steroid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025191 pages

Choose your research edition.

Industry ResearchAndrogen and Anabolic Steroid Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Androgen and Anabolic Steroid Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Androgen and Anabolic Steroid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Androgen and Anabolic Steroid Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Androgen and Anabolic Steroid Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Androgen and Anabolic Steroid market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Androgen and Anabolic Steroid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Androgen and Anabolic Steroid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Androgen and Anabolic Steroid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Androgen and Anabolic Steroid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Androgen and Anabolic Steroid include Acerus Pharmaceuticals, Amneal Pharmaceuticals, Antares Pharma, Auxilium Pharmaceuticals, Bausch Health, Clarus Therapeutics, Endo Pharmaceuticals, Pharmacia and Upjohn and Solvay Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Androgen and Anabolic Steroid market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Androgen and Anabolic Steroid and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Androgen and Anabolic Steroid sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Androgen and Anabolic Steroid market size, projected growth trends, production technologies, key applications, and end-use industries.

Androgen and Anabolic Steroid Segment by Company

Acerus Pharmaceuticals

Amneal Pharmaceuticals

Antares Pharma

Auxilium Pharmaceuticals

Bausch Health

Clarus Therapeutics

Endo Pharmaceuticals

Pharmacia and Upjohn

Solvay Pharmaceuticals

Upsher-Smith

AbbVie

GlaxoSmithKline

Pfizer

Teva

Androgen and Anabolic Steroid Segment by Type

Methyltestosterone

Testosterone

Fluoxymesterone

Others

Androgen and Anabolic Steroid Segment by Application

Hospitals

Pharmacy

Others

Androgen and Anabolic Steroid Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Androgen and Anabolic Steroid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Androgen and Anabolic Steroid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Androgen and Anabolic Steroid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Androgen and Anabolic Steroid market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Androgen and Anabolic Steroid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Androgen and Anabolic Steroid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Androgen and Anabolic Steroid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Androgen and Anabolic Steroid Industry Trends Table 2. Androgen and Anabolic Steroid Industry Drivers Table 3. Androgen and Anabolic Steroid Industry Opportunities and Challenges Table 4. Androgen and Anabolic Steroid Industry Restraints Table 5. Global Androgen and Anabolic Steroid Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Androgen and Anabolic Steroid Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Androgen and Anabolic Steroid Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Androgen and Anabolic Steroid Sales Market Share by Manufacturers Table 9. Global Androgen and Anabolic Steroid Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Androgen and Anabolic Steroid Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Androgen and Anabolic Steroid Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Androgen and Anabolic Steroid Manufacturers, Product Type & Application Table 13. Global Androgen and Anabolic Steroid Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Androgen and Anabolic Steroid by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Methyltestosterone Table 17. Major Manufacturers of Testosterone Table 18. Major Manufacturers of Fluoxymesterone Table 19. Major Manufacturers of Others Table 20. Global Androgen and Anabolic Steroid Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Androgen and Anabolic Steroid Sales by Type (2021-2026) & (K Units) Table 22. Global Androgen and Anabolic Steroid Sales by Type (2027-2032) & (K Units) Table 23. Global Androgen and Anabolic Steroid Sales Market Share by Type (2021-2026) Table 24. Global Androgen and Anabolic Steroid Sales Market Share by Type (2027-2032) Table 25. Global Androgen and Anabolic Steroid Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Androgen and Anabolic Steroid Revenue by Type (2021-2026) & (K Units) Table 27. Global Androgen and Anabolic Steroid Revenue by Type (2027-2032) & (K Units) Table 28. Global Androgen and Anabolic Steroid Revenue Market Share by Type (2021-2026) Table 29. Global Androgen and Anabolic Steroid Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospitals Table 31. Major Manufacturers of Pharmacy Table 32. Major Manufacturers of Others Table 33. Global Androgen and Anabolic Steroid Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Androgen and Anabolic Steroid Sales by Application (2021-2026) & (K Units) Table 35. Global Androgen and Anabolic Steroid Sales by Application (2027-2032) & (K Units) Table 36. Global Androgen and Anabolic Steroid Sales Market Share by Application (2021-2026) Table 37. Global Androgen and Anabolic Steroid Sales Market Share by Application (2027-2032) Table 38. Global Androgen and Anabolic Steroid Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Androgen and Anabolic Steroid Revenue by Application (2021-2026) & (K Units) Table 40. Global Androgen and Anabolic Steroid Revenue by Application (2027-2032) & (K Units) Table 41. Global Androgen and Anabolic Steroid Revenue Market Share by Application (2021-2026) Table 42. Global Androgen and Anabolic Steroid Revenue Market Share by Application (2027-2032) Table 43. Global Androgen and Anabolic Steroid Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Androgen and Anabolic Steroid Sales by Region (2021-2026) & (K Units) Table 45. Global Androgen and Anabolic Steroid Sales Market Share by Region (2021-2026) Table 46. Global Androgen and Anabolic Steroid Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Androgen and Anabolic Steroid Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Androgen and Anabolic Steroid Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Androgen and Anabolic Steroid Sales by Country (2021-2026) & (K Units) Table 50. North America Androgen and Anabolic Steroid Sales by Country (2027-2032) & (K Units) Table 51. Europe Androgen and Anabolic Steroid Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Androgen and Anabolic Steroid Sales by Country (2021-2026) & (K Units) Table 53. Europe Androgen and Anabolic Steroid Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Androgen and Anabolic Steroid Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Androgen and Anabolic Steroid Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Androgen and Anabolic Steroid Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Androgen and Anabolic Steroid Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Androgen and Anabolic Steroid Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Androgen and Anabolic Steroid Sales by Country (2027-2032) & (K Units) Table 60. Global Androgen and Anabolic Steroid Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Androgen and Anabolic Steroid Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Androgen and Anabolic Steroid Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Androgen and Anabolic Steroid Revenue Market Share by Region (2021-2026) Table 64. Global Androgen and Anabolic Steroid Revenue Market Share by Region (2027-2032) Table 65. Acerus Pharmaceuticals Company Information Table 66. Acerus Pharmaceuticals Business Overview Table 67. Acerus Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Acerus Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio Table 69. Acerus Pharmaceuticals Recent Development Table 70. Amneal Pharmaceuticals Company Information Table 71. Amneal Pharmaceuticals Business Overview Table 72. Amneal Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Amneal Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio Table 74. Amneal Pharmaceuticals Recent Development Table 75. Antares Pharma Company Information Table 76. Antares Pharma Business Overview Table 77. Antares Pharma Androgen and Anabolic Steroid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Antares Pharma Androgen and Anabolic Steroid Product Portfolio Table 79. Antares Pharma Recent Development Table 80. Auxilium Pharmaceuticals Company Information Table 81. Auxilium Pharmaceuticals Business Overview Table 82. Auxilium Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Auxilium Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio Table 84. Auxilium Pharmaceuticals Recent Development Table 85. Bausch Health Company Information Table 86. Bausch Health Business Overview Table 87. Bausch Health Androgen and Anabolic Steroid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Bausch Health Androgen and Anabolic Steroid Product Portfolio Table 89. Bausch Health Recent Development Table 90. Clarus Therapeutics Company Information Table 91. Clarus Therapeutics Business Overview Table 92. Clarus Therapeutics Androgen and Anabolic Steroid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Clarus Therapeutics Androgen and Anabolic Steroid Product Portfolio Table 94. Clarus Therapeutics Recent Development Table 95. Endo Pharmaceuticals Company Information Table 96. Endo Pharmaceuticals Business Overview Table 97. Endo Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Endo Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio Table 99. Endo Pharmaceuticals Recent Development Table 100. Pharmacia and Upjohn Company Information Table 101. Pharmacia and Upjohn Business Overview Table 102. Pharmacia and Upjohn Androgen and Anabolic Steroid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Pharmacia and Upjohn Androgen and Anabolic Steroid Product Portfolio Table 104. Pharmacia and Upjohn Recent Development Table 105. Solvay Pharmaceuticals Company Information Table 106. Solvay Pharmaceuticals Business Overview Table 107. Solvay Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Solvay Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio Table 109. Solvay Pharmaceuticals Recent Development Table 110. Upsher-Smith Company Information Table 111. Upsher-Smith Business Overview Table 112. Upsher-Smith Androgen and Anabolic Steroid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Upsher-Smith Androgen and Anabolic Steroid Product Portfolio Table 114. Upsher-Smith Recent Development Table 115. AbbVie Company Information Table 116. AbbVie Business Overview Table 117. AbbVie Androgen and Anabolic Steroid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. AbbVie Androgen and Anabolic Steroid Product Portfolio Table 119. AbbVie Recent Development Table 120. GlaxoSmithKline Company Information Table 121. GlaxoSmithKline Business Overview Table 122. GlaxoSmithKline Androgen and Anabolic Steroid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. GlaxoSmithKline Androgen and Anabolic Steroid Product Portfolio Table 124. GlaxoSmithKline Recent Development Table 125. Pfizer Company Information Table 126. Pfizer Business Overview Table 127. Pfizer Androgen and Anabolic Steroid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Pfizer Androgen and Anabolic Steroid Product Portfolio Table 129. Pfizer Recent Development Table 130. Teva Company Information Table 131. Teva Business Overview Table 132. Teva Androgen and Anabolic Steroid Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Teva Androgen and Anabolic Steroid Product Portfolio Table 134. Teva Recent Development Table 135. Key Raw Materials Table 136. Raw Materials Key Suppliers Table 137. Androgen and Anabolic Steroid Distributors List Table 138. Androgen and Anabolic Steroid Customers List Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Androgen and Anabolic Steroid Product Image Figure 2. Global Androgen and Anabolic Steroid Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Androgen and Anabolic Steroid Market Size (2021-2032) & (US$ Million) Figure 4. Global Androgen and Anabolic Steroid Sales (2021-2032) & (K Units) Figure 5. Global Androgen and Anabolic Steroid Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Androgen and Anabolic Steroid Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Methyltestosterone Image Figure 9. Testosterone Image Figure 10. Fluoxymesterone Image Figure 11. Others Image Figure 12. Global Androgen and Anabolic Steroid Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Androgen and Anabolic Steroid Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Androgen and Anabolic Steroid Sales Market Share by Type (2021-2032) Figure 15. Global Androgen and Anabolic Steroid Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Androgen and Anabolic Steroid Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Androgen and Anabolic Steroid Revenue Market Share by Type (2021-2032) Figure 18. Hospitals Image Figure 19. Pharmacy Image Figure 20. Others Image Figure 21. Global Androgen and Anabolic Steroid Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Androgen and Anabolic Steroid Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Androgen and Anabolic Steroid Sales Market Share by Application (2021-2032) Figure 24. Global Androgen and Anabolic Steroid Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Androgen and Anabolic Steroid Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Androgen and Anabolic Steroid Revenue Market Share by Application (2021-2032) Figure 27. North America Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Androgen and Anabolic Steroid Sales Market Share by Country (2021-2032) Figure 29. U.S. Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Androgen and Anabolic Steroid Sales Market Share by Country (2021-2032) Figure 34. Germany Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Androgen and Anabolic Steroid Sales Market Share by Country (2021-2032) Figure 41. China Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Androgen and Anabolic Steroid Sales Market Share by Country (2021-2032) Figure 49. Brazil Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Androgen and Anabolic Steroid Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Androgen and Anabolic Steroid Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Androgen and Anabolic Steroid Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Androgen and Anabolic Steroid Revenue (2021-2032) & (US$ Million) Figure 60. North America Androgen and Anabolic Steroid Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Androgen and Anabolic Steroid Revenue (2021-2032) & (US$ Million) Figure 62. Europe Androgen and Anabolic Steroid Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Androgen and Anabolic Steroid Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Androgen and Anabolic Steroid Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Androgen and Anabolic Steroid Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Androgen and Anabolic Steroid Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Androgen and Anabolic Steroid Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Androgen and Anabolic Steroid Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Methyltestosterone
  • Testosterone
  • Fluoxymesterone
  • Others
Applications
  • Hospitals
  • Pharmacy
  • Others
Companies covered
  • Acerus Pharmaceuticals
  • Amneal Pharmaceuticals
  • Antares Pharma
  • Auxilium Pharmaceuticals
  • Bausch Health
  • Clarus Therapeutics
  • Endo Pharmaceuticals
  • Pharmacia and Upjohn
  • Solvay Pharmaceuticals
  • Upsher-Smith
  • AbbVie
  • GlaxoSmithKline
  • Pfizer
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Androgen and Anabolic Steroid Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Androgen and Anabolic Steroid Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Androgen and Anabolic Steroid Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Androgen and Anabolic Steroid Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Androgen and Anabolic Steroid Market Dynamics
  1. 2.1 Androgen and Anabolic Steroid Industry Trends
  2. 2.2 Androgen and Anabolic Steroid Industry Drivers
  3. 2.3 Androgen and Anabolic Steroid Industry Opportunities and Challenges
  4. 2.4 Androgen and Anabolic Steroid Industry Restraints
3 Androgen and Anabolic Steroid Market by Manufacturers
  1. 3.1 Global Androgen and Anabolic Steroid Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Androgen and Anabolic Steroid Sales by Manufacturers (2021-2026)
  3. 3.3 Global Androgen and Anabolic Steroid Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Androgen and Anabolic Steroid Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Androgen and Anabolic Steroid Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Androgen and Anabolic Steroid Manufacturers, Product Type & Application
  7. 3.7 Global Androgen and Anabolic Steroid Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Androgen and Anabolic Steroid Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Androgen and Anabolic Steroid Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Androgen and Anabolic Steroid Tier 1, Tier 2, and Tier 3
4 Androgen and Anabolic Steroid Market by Type
  1. 4.1 Androgen and Anabolic Steroid Type Introduction
  2. 4.1.1 Methyltestosterone
  3. 4.1.2 Testosterone
  4. 4.1.3 Fluoxymesterone
  5. 4.1.4 Others
  6. 4.2 Global Androgen and Anabolic Steroid Sales by Type
  7. 4.2.1 Global Androgen and Anabolic Steroid Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Androgen and Anabolic Steroid Sales by Type (2021-2032)
  9. 4.2.3 Global Androgen and Anabolic Steroid Sales Market Share by Type (2021-2032)
  10. 4.3 Global Androgen and Anabolic Steroid Revenue by Type
  11. 4.3.1 Global Androgen and Anabolic Steroid Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Androgen and Anabolic Steroid Revenue by Type (2021-2032)
  13. 4.3.3 Global Androgen and Anabolic Steroid Revenue Market Share by Type (2021-2032)
5 Androgen and Anabolic Steroid Market by Application
  1. 5.1 Androgen and Anabolic Steroid Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Pharmacy
  4. 5.1.3 Others
  5. 5.2 Global Androgen and Anabolic Steroid Sales by Application
  6. 5.2.1 Global Androgen and Anabolic Steroid Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Androgen and Anabolic Steroid Sales by Application (2021-2032)
  8. 5.2.3 Global Androgen and Anabolic Steroid Sales Market Share by Application (2021-2032)
  9. 5.3 Global Androgen and Anabolic Steroid Revenue by Application
  10. 5.3.1 Global Androgen and Anabolic Steroid Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Androgen and Anabolic Steroid Revenue by Application (2021-2032)
  12. 5.3.3 Global Androgen and Anabolic Steroid Revenue Market Share by Application (2021-2032)
6 Global Androgen and Anabolic Steroid Sales by Region
  1. 6.1 Global Androgen and Anabolic Steroid Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Androgen and Anabolic Steroid Sales by Region (2021-2032)
  3. 6.2.1 Global Androgen and Anabolic Steroid Sales by Region (2021-2026)
  4. 6.2.2 Global Androgen and Anabolic Steroid Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Androgen and Anabolic Steroid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Androgen and Anabolic Steroid Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Androgen and Anabolic Steroid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Androgen and Anabolic Steroid Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Androgen and Anabolic Steroid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Androgen and Anabolic Steroid Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Androgen and Anabolic Steroid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Androgen and Anabolic Steroid Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Androgen and Anabolic Steroid Revenue by Region
  1. 7.1 Global Androgen and Anabolic Steroid Revenue by Region
  2. 7.1.1 Global Androgen and Anabolic Steroid Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Androgen and Anabolic Steroid Revenue by Region (2021-2026)
  4. 7.1.3 Global Androgen and Anabolic Steroid Revenue by Region (2027-2032)
  5. 7.1.4 Global Androgen and Anabolic Steroid Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Androgen and Anabolic Steroid Revenue (2021-2032)
  8. 7.2.2 North America Androgen and Anabolic Steroid Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Androgen and Anabolic Steroid Revenue (2021-2032)
  11. 7.3.2 Europe Androgen and Anabolic Steroid Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Androgen and Anabolic Steroid Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Androgen and Anabolic Steroid Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Androgen and Anabolic Steroid Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Androgen and Anabolic Steroid Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Acerus Pharmaceuticals
  2. 8.1.1 Acerus Pharmaceuticals Company Information
  3. 8.1.2 Acerus Pharmaceuticals Business Overview
  4. 8.1.3 Acerus Pharmaceuticals Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Acerus Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio
  6. 8.1.5 Acerus Pharmaceuticals Recent Developments
  7. 8.2 Amneal Pharmaceuticals
  8. 8.2.1 Amneal Pharmaceuticals Company Information
  9. 8.2.2 Amneal Pharmaceuticals Business Overview
  10. 8.2.3 Amneal Pharmaceuticals Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Amneal Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio
  12. 8.2.5 Amneal Pharmaceuticals Recent Developments
  13. 8.3 Antares Pharma
  14. 8.3.1 Antares Pharma Company Information
  15. 8.3.2 Antares Pharma Business Overview
  16. 8.3.3 Antares Pharma Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Antares Pharma Androgen and Anabolic Steroid Product Portfolio
  18. 8.3.5 Antares Pharma Recent Developments
  19. 8.4 Auxilium Pharmaceuticals
  20. 8.4.1 Auxilium Pharmaceuticals Company Information
  21. 8.4.2 Auxilium Pharmaceuticals Business Overview
  22. 8.4.3 Auxilium Pharmaceuticals Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Auxilium Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio
  24. 8.4.5 Auxilium Pharmaceuticals Recent Developments
  25. 8.5 Bausch Health
  26. 8.5.1 Bausch Health Company Information
  27. 8.5.2 Bausch Health Business Overview
  28. 8.5.3 Bausch Health Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bausch Health Androgen and Anabolic Steroid Product Portfolio
  30. 8.5.5 Bausch Health Recent Developments
  31. 8.6 Clarus Therapeutics
  32. 8.6.1 Clarus Therapeutics Company Information
  33. 8.6.2 Clarus Therapeutics Business Overview
  34. 8.6.3 Clarus Therapeutics Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Clarus Therapeutics Androgen and Anabolic Steroid Product Portfolio
  36. 8.6.5 Clarus Therapeutics Recent Developments
  37. 8.7 Endo Pharmaceuticals
  38. 8.7.1 Endo Pharmaceuticals Company Information
  39. 8.7.2 Endo Pharmaceuticals Business Overview
  40. 8.7.3 Endo Pharmaceuticals Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Endo Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio
  42. 8.7.5 Endo Pharmaceuticals Recent Developments
  43. 8.8 Pharmacia and Upjohn
  44. 8.8.1 Pharmacia and Upjohn Company Information
  45. 8.8.2 Pharmacia and Upjohn Business Overview
  46. 8.8.3 Pharmacia and Upjohn Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pharmacia and Upjohn Androgen and Anabolic Steroid Product Portfolio
  48. 8.8.5 Pharmacia and Upjohn Recent Developments
  49. 8.9 Solvay Pharmaceuticals
  50. 8.9.1 Solvay Pharmaceuticals Company Information
  51. 8.9.2 Solvay Pharmaceuticals Business Overview
  52. 8.9.3 Solvay Pharmaceuticals Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Solvay Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio
  54. 8.9.5 Solvay Pharmaceuticals Recent Developments
  55. 8.10 Upsher-Smith
  56. 8.10.1 Upsher-Smith Company Information
  57. 8.10.2 Upsher-Smith Business Overview
  58. 8.10.3 Upsher-Smith Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Upsher-Smith Androgen and Anabolic Steroid Product Portfolio
  60. 8.10.5 Upsher-Smith Recent Developments
  61. 8.11 AbbVie
  62. 8.11.1 AbbVie Company Information
  63. 8.11.2 AbbVie Business Overview
  64. 8.11.3 AbbVie Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 AbbVie Androgen and Anabolic Steroid Product Portfolio
  66. 8.11.5 AbbVie Recent Developments
  67. 8.12 GlaxoSmithKline
  68. 8.12.1 GlaxoSmithKline Company Information
  69. 8.12.2 GlaxoSmithKline Business Overview
  70. 8.12.3 GlaxoSmithKline Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 GlaxoSmithKline Androgen and Anabolic Steroid Product Portfolio
  72. 8.12.5 GlaxoSmithKline Recent Developments
  73. 8.13 Pfizer
  74. 8.13.1 Pfizer Company Information
  75. 8.13.2 Pfizer Business Overview
  76. 8.13.3 Pfizer Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Pfizer Androgen and Anabolic Steroid Product Portfolio
  78. 8.13.5 Pfizer Recent Developments
  79. 8.14 Teva
  80. 8.14.1 Teva Company Information
  81. 8.14.2 Teva Business Overview
  82. 8.14.3 Teva Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Teva Androgen and Anabolic Steroid Product Portfolio
  84. 8.14.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Androgen and Anabolic Steroid Value Chain Analysis
  2. 9.1.1 Androgen and Anabolic Steroid Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Androgen and Anabolic Steroid Production Mode & Process
  6. 9.2 Androgen and Anabolic Steroid Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Androgen and Anabolic Steroid Distributors
  9. 9.2.3 Androgen and Anabolic Steroid Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst